PLEOMORPHIC VARIANT MANTLE CELL LYMPHOMA

Clinical trials for PLEOMORPHIC VARIANT MANTLE CELL LYMPHOMA explained in plain language.

Never miss a new study

Get alerted when new PLEOMORPHIC VARIANT MANTLE CELL LYMPHOMA trials appear

Sign up with your email to follow new studies for PLEOMORPHIC VARIANT MANTLE CELL LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 2

Triple-Threat attack on Tough-to-Treat blood cancer

Disease control Recruiting now

This study is testing a new combination of three drugs (glofitamab, venetoclax, and lenalidomide) for people newly diagnosed with a high-risk form of mantle cell lymphoma, a type of blood cancer. The goal is to see if this three-drug approach is safe and can keep the cancer from …

Matched conditions: PLEOMORPHIC VARIANT MANTLE CELL LYMPHOMA

Phase: PHASE1, PHASE2 • Sponsor: City of Hope Medical Center • Aim: Disease control

Last updated Mar 23, 2026 15:15 UTC

PLEOMORPHIC VARIANT MANTLE CELL LYMPHOMA

Get alerted when new PLEOMORPHIC VARIANT MANTLE CELL LYMPHOMA trials appear

Triple-Threat attack on Tough-to-Treat blood cancer